Member You
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Medicine > FDA Approves New Drug to Fight Severe Breast Cancer

Tags

  • expand
  • according
  • estate
  • fighting breast
  • cancer after
  • heart function

  • Links

  • Atkins Answer for Obesity Problem
  • Natural Health Remedies - Debugging the Myths
  • Soccer Tips - Soccer Betting, The New Investment
  • Member You - FDA Approves New Drug to Fight Severe Breast Cancer

    Aromatherapy-Getting Started
    Getting started with aromatherapy is not particularly difficult and can be done with only a couple of items but it can also be a very complex science. It is generally considered by most people to be anything t
    tatic breast cancer that was HER2 positive. Common side effects included diarrhea, nausea, vomiting, and rash. A small percentage of participants also had a decrease in heart function that may have been characterized by shortness of breath.”

    Although this medic

    Procurement
    The range of activities associated with the buying of goods and services to support business operations is called procurement. When talking about procurement, planning is the first and most important step in th
    On March 13, the FDA approved a new drug that in recent clinical trials, delayed the spread of advanced breast cancer who were no longer showing any reaction to Hereceptin. Hereceptin is a drug which affectively combats cancerous tumors filled with too much HER-2 protein.

    The new drug called Tykerb, couple with chemotherapy, has show in clinical trials to do a better job of fighting breast cancer than chemo alone.

    Dr. Steven Galson, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research said, “Today's approval is a step forward in making new treatments available for patients who have progression of their breast cancer after treatment with some of the most effective breast cancer therapies available. New targeted therapies such as Tykerb are helping expand options for patients.”

    I hope the results of this study will save the lives of the nearly 10,000 women who die each year from this type of cancer. According to HealthDay, “The drug was tested in a trial involving 400 women with advanced or metastatic breast cancer that was HER2 positive. Common side effects included diarrhea, nausea, vomiting, and rash. A small percentage of participants also had a decrease in heart function that may have been characterized by shortness of breath.”

    Although this medic

    5 Ways To Decide On A Major
    You Know This Is What You Were Born To Study This way is undoubtedly the easiest. It seems like some people are born with a passion or anthropology or architecture. Maybe they are, maybe they're not, but by th
    otein.

    The new drug called Tykerb, couple with chemotherapy, has show in clinical trials to do a better job of fighting breast cancer than chemo alone.

    Dr. Steven Galson, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research said, “Today's approval is a step forward in making new treatments available for patients who have progression of their breast cancer after treatment with some of the most effective breast cancer therapies available. New targeted therapies such as Tykerb are helping expand options for patients.”

    I hope the results of this study will save the lives of the nearly 10,000 women who die each year from this type of cancer. According to HealthDay, “The drug was tested in a trial involving 400 women with advanced or metastatic breast cancer that was HER2 positive. Common side effects included diarrhea, nausea, vomiting, and rash. A small percentage of participants also had a decrease in heart function that may have been characterized by shortness of breath.”

    Although this medic

    Introduction To Blogging - How To Build Customer Relationships
    The term blog comes from the word iweblog. Blogs have been around for approximately 6 years in their current form - as a digital journal maintained by one or more authors. The
    esearch said, “Today's approval is a step forward in making new treatments available for patients who have progression of their breast cancer after treatment with some of the most effective breast cancer therapies available. New targeted therapies such as Tykerb are helping expand options for patients.”

    I hope the results of this study will save the lives of the nearly 10,000 women who die each year from this type of cancer. According to HealthDay, “The drug was tested in a trial involving 400 women with advanced or metastatic breast cancer that was HER2 positive. Common side effects included diarrhea, nausea, vomiting, and rash. A small percentage of participants also had a decrease in heart function that may have been characterized by shortness of breath.”

    Although this medic

    7 Tips for Better Ads
    The content of advertising is basically the same no matter what the media. It is good and it works, or it is bad. Some TV ads are so clever people tend to remember the cleverness and forget the product.
    helping expand options for patients.”

    I hope the results of this study will save the lives of the nearly 10,000 women who die each year from this type of cancer. According to HealthDay, “The drug was tested in a trial involving 400 women with advanced or metastatic breast cancer that was HER2 positive. Common side effects included diarrhea, nausea, vomiting, and rash. A small percentage of participants also had a decrease in heart function that may have been characterized by shortness of breath.”

    Although this medic

    High Tension for the Buyer and Seller of Real Estate Can Be Reduced
    Tensions can run high in both the selling and buying of real estate. After all, there is a lot of money and emotion involved! There are also time pressures and numerous privacy issues to deal with. The sale and
    tatic breast cancer that was HER2 positive. Common side effects included diarrhea, nausea, vomiting, and rash. A small percentage of participants also had a decrease in heart function that may have been characterized by shortness of breath.”

    Although this medication may go on to save the lives of many women, the FDA should not allow companies who have interest in the outcome of the study be the one who funds and conducts it. Anyone who has interest in the outcome of any event will always do what is in their power to protect their interest. Like the old adage goes. “You ain’t cheatin, You ain’t tryin .”

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.memberyou.net/article/251813/memberyou-FDA-Approves-New-Drug-to-Fight-Severe-Breast-Cancer.html">FDA Approves New Drug to Fight Severe Breast Cancer</a>

    BB link (for phorums):
    [url=http://www.memberyou.net/article/251813/memberyou-FDA-Approves-New-Drug-to-Fight-Severe-Breast-Cancer.html]FDA Approves New Drug to Fight Severe Breast Cancer[/url]

    Related Articles:

    The Web Design - Development - SEO Market in the Dominican Republic

    Self Directed IRA with Checkbook Control

    LG U300 – A Bluetooth Compatible Handset With Multimedia Options

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com